eca2026-808 - Information Regarding the Reverse Stock Split, Par Value and CUSIP Number Change Silexion Therapeutics Corp. (SLXN)

Open the sourceReported by Nasdaq Trader, nasdaqtrader.com, 9 November 2026

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Muhabbit only has the headline for this one. The full report is at nasdaqtrader.com.